Bayer (BAYN) PT Set at €124.00 by Berenberg Bank

Bayer (FRA:BAYN) received a €124.00 ($147.62) target price from analysts at Berenberg Bank in a note issued to investors on Tuesday. The brokerage presently has a “neutral” rating on the healthcare company’s stock. Berenberg Bank’s price target indicates a potential upside of 18.72% from the stock’s previous close.

Several other equities research analysts also recently weighed in on the company. J P Morgan Chase & Co reissued a “buy” rating on shares of Bayer in a report on Wednesday, September 13th. Commerzbank set a €124.00 ($147.62) price objective on Bayer and gave the company a “buy” rating in a report on Wednesday, November 15th. Barclays set a €105.00 ($125.00) price objective on Bayer and gave the company a “sell” rating in a report on Friday, November 17th. UBS set a €125.00 ($148.81) price objective on Bayer and gave the company a “buy” rating in a report on Monday, November 6th. Finally, Goldman Sachs Group set a €125.00 ($148.81) target price on Bayer and gave the stock a “buy” rating in a report on Tuesday, November 7th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and fourteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of €122.19 ($145.46).

Bayer (FRA:BAYN) opened at €104.45 ($124.35) on Tuesday. Bayer has a 52 week low of €86.60 ($103.10) and a 52 week high of €123.82 ($147.40).

TRADEMARK VIOLATION NOTICE: This piece of content was published by Ticker Report and is the property of of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.tickerreport.com/banking-finance/3078905/bayer-bayn-pt-set-at-124-00-by-berenberg-bank.html.

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women?s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


Leave a Reply

© 2006-2017 Ticker Report. Google+.